Dr. Mack Roach III presented “Updates in Brachytherapy” at the 27th annual...Read More
Mack Roach, III, MD
Professor of Radiation Oncology and Urology University of California, San Francisco
San Francisco, CA
Mack Roach III, MD, is a Professor of Radiation Oncology, Medical Oncology and Urology, at the University of California, San Francisco. He earned his MD from Stanford University School of Medicine. Over the last 10 years, his research efforts have been directed at defining optimal imaging modalities, as well as criteria for defining target volumes and improved treatment techniques. Dr. Roach chaired one of the most important large prospective randomized trials comparing different strategies for locally advanced prostate cancer. He has gained international recognition as an authority on treatment planning for prostate cancer and served as senior author for the guidelines for treatment planning recently published by the American College of Radiology. Dr. Roach is a member of several professional societies including the American Society of Clinical Oncology, American Society for Therapeutic Radiology and Oncology, Radiation Therapy Oncology Group, the NCI IMRT Working Group and American Joint Commission for Cancer (AJCC) Staging (GU), the American Cancer Society (ACS) Task for Cancer Screening Guidelines (Prostate cancer) and the NCI Concept Evaluation Panel (Prostate Cancer Phase III Trials). His major research interest involves the application of 3-D conformal and intensity modulated radiotherapy (IMRT) treatment planning technology as a major component of combined modality management of prostate cancer and other solid tumors.